Berylson Capital Partners, LLC Wave Life Sciences Ltd. Transaction History

Berylson Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.99 - $37.6 $1.22 Million - $5.72 Million	-152,228 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $371,371 - $501,601	-10,010 Reduced 6.17%	152,228 $6.4 Million
Q4 2017 Feb 14, 2018	BUY	$21.8 - $39.35 $3.54 Million - $6.38 Million	162,238	162,238 $5.7 Million

132

71.8M

86.1K

20.1K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $475M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Berylson Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Berylson Capital Partners, LLC with notifications on news.